FY26 OGT Equipment - Imaging and Incubators
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- tbd@fda.gov
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a procurement for Imaging and Incubators equipment for the Office of Generic Drugs (OGT) in Fiscal Year 2026. The equipment is essential for continuing research aligned with the FDA and OTP mission, with an estimated solicitation release date of July 1, 2026, and a projected contract award date of September 1, 2026. This procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS code 334516, indicating specialized scientific equipment requirements.
While specific award values are not disclosed, the contract appears targeted at supporting critical laboratory research capabilities. The point of contact for this opportunity includes Joshua Holliday (joshua.holliday@fda.hhs.gov) from the FDA, who can likely provide more detailed information about the specific equipment needs. The forecast suggests this is a new requirement with no specific set-aside, potentially opening the opportunity to a broad range of qualified laboratory equipment manufacturers and suppliers who can meet the FDA's specialized research instrument requirements.
Forecast text
Necessary equipment to continue research as it pertains to the FDA and OTP mission.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast